Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STAT-LUNG: Perioperative Atorvastatin for Prevention of Atrial Fibrillation After Lung Resection
NCT07727681Phase 4Recruiting
- Sponsor
- Peking Union Medical College Hospital
- Start
- Aug 2026
- Primary completion
- Sep 2027
- Countries
- 1
01
Overview
A Phase 4 trial of atorvastatin in Atrial fibrillation (AFib), sponsored by Peking Union Medical College Hospital. Started Aug 2026; status: recruiting.
02
Drugs
atorvastatin
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT07727681.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07727681.